Key gut microbiota pathways, such as PWY-7328 (involved in O-antigen biosynthesis) and GLCMANNANAUT-PWY (involved in N-acetylglucosamine degradation), were associated with LOAD and CSF p-tau levels, indicating the role of gut microbiota-driven products in AD pathology. Here, MAPT is linked to Alzheimer disease.